Boxer Capital, LLC - MEI PHARMA INC ownership

Quarter-by-quarter ownership
Boxer Capital, LLC ownership history of MEI PHARMA INC
ValueSharesWeighting
Q2 2023$958
+43.6%
145,654
-95.0%
0.04%
+33.3%
Q1 2023$667
-99.9%
2,913,0910.0%0.03%
-10.8%
Q4 2022$709,629
-37.0%
2,913,0910.0%0.04%
-41.3%
Q3 2022$1,126,000
-36.1%
2,913,0910.0%0.06%
-43.8%
Q2 2022$1,762,000
+0.4%
2,913,0910.0%0.11%
+24.4%
Q1 2022$1,755,000
-77.4%
2,913,0910.0%0.09%
-70.2%
Q4 2021$7,778,000
-3.3%
2,913,0910.0%0.30%
+7.5%
Q3 2021$8,040,000
-3.2%
2,913,0910.0%0.28%
-4.1%
Q2 2021$8,302,000
-16.9%
2,913,0910.0%0.29%
-13.6%
Q1 2021$9,992,000
+29.9%
2,913,0910.0%0.34%
+37.2%
Q4 2020$7,691,000
-15.4%
2,913,0910.0%0.25%
-21.3%
Q3 2020$9,089,000
-24.5%
2,913,0910.0%0.31%
-40.6%
Q2 2020$12,031,000
+156.5%
2,913,0910.0%0.53%
+65.3%
Q1 2020$4,690,000
-35.1%
2,913,0910.0%0.32%
-21.8%
Q4 2019$7,224,000
+47.6%
2,913,0910.0%0.41%
+15.2%
Q3 2019$4,894,000
-32.8%
2,913,0910.0%0.36%
-43.3%
Q2 2019$7,283,000
-18.6%
2,913,0910.0%0.63%
-39.5%
Q1 2019$8,943,000
+16.3%
2,913,0910.0%1.03%
+8.8%
Q4 2018$7,691,000
-38.7%
2,913,0910.0%0.95%
-31.8%
Q3 2018$12,555,000
+9.4%
2,913,0910.0%1.39%
+7.2%
Q2 2018$11,478,0002,913,0911.30%
Other shareholders
MEI PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
TLS Advisors LLC 2,010,285$4902.42%
Anson Funds Management LP 10,617,959$2,586,5350.43%
NEA Management Company, LLC 8,533,072$2,078,6560.12%
Boxer Capital, LLC 2,913,091$709,6290.04%
Investmark Advisory Group LLC 136,000$33,1300.02%
CARLSON CAPITAL L P 1,180,000$287,4480.02%
Mesirow Financial Investment Management, Inc. 20,486$4,9900.02%
Artal Group S.A. 1,000,000$2440.01%
Annandale Capital, LLC 100,000$240.01%
ACADIAN ASSET MANAGEMENT LLC 4,758,364$1,1580.01%
View complete list of MEI PHARMA INC shareholders